BIOVOMED

Biovomed is an Italian biotechnology company focused on the development of next-generation biological medical devices for cardiovascular and vascular surgery. A spin-off from the University of Padua, the company utilizes a proprietary decellularization platform to create biocompatible scaffolds from animal-derived tissues. Their lead product, the V-Patch, is a decellularized bovine pericardium designed for cardiac and vascular reconstruction, offering reduced immunogenicity and improved integration compared to traditional glutaraldehyde-treated tissues. Biovomed's pipeline also includes the V-Graft for vascular bypass and advanced heart valve replacement solutions. By combining tissue engineering with clinical expertise, the company aims to provide surgeons with regenerative solutions that enhance patient recovery and long-term outcomes.